This finding is counterintuitive, considering that the literature indicates that females are less susceptible to metabolic disorders and liver disease due to factors such as reduced expression of nuclear receptors like PPARα, increased activation of glucocorticoid receptors, and increased expression of xenobiotic receptors allowing for enhanced detoxification of xenobiotic compounds compared to males [50,51]. This evidence concerns the gene NR3C1 and liver disorder.